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most likely, "ifit could be made, it could be
sold." One ofthe problems that the compa-
ny would face in trying to sell the fuel is its
high price tag, which is due to production
costs and feedstock costs, or costs of the
materials needed for production, according
to Mann.
But much more research needs to be
done before these issues are decided.
Simplot will continue to follow the research
on biodiesel, while the University of Idaho
tries to work out the problems. Mann said
the major problem the researchers now face
involves the differences between raw veg-
etable oil and waste vegetable oil. He said
that the oil used in the production offrench
fries is chemically modified in its raw state
in order to raise its melting point, thus
improving its ability to cook french fries. At
the same time, this chemical modification
also raises the oil's cloud point, the tempera-
ture at which solids begin to form. This
poses a problem when used in biodiesel,
because the fuel has to be kept at a certain
temperature to prevent it from crystallizing.
If the fuel has a high cloud point, it will
crystallize at low temperatures during the
winter. Researchers are now trying to lower
the cloud point ofthe biodiesel made from
wastevegetable oil.
IfSimplot markets biodiesel, the compa-
ny would focus on the environmental bene-
fits ofthe fuel, marketing it for use by trucks,
buses, and heavy machinery in environmen-
tally sensitive or smog-prone areas. The suc-
cess of biodiesel would depend on whether
potential consumers believe the environmen-
tal benefits outweigh the costs. New air quali-
ty regulations and national mandates are
being introduced that urge government and
industry to begin using alternative fuels. Such
regulations could raise interest in biodiesel.
Because ofthe high price, however, biodiesel
would probably not be sold at the corner
pump, Mann said. Simplot will await the
outcomes ofthis research before making any
decisions about investment. "We're not going
to jump in with both feet tomorrow," Mann
said. "But it could be an opportunity in the
future because we do have two of the major
ingredients."
The Waning War on Cancer
The ongoing war on cancer, declared by
President Nixon in 1971, needs to be revital-
ized or it will be lost, says a subcommittee of
the National Cancer Advisory Board. Unless
changes are made in the current strategy,
cancer will become the nation's top killer in
just five years, the subcommittee says.
The subcommittee to evaluate the
National Cancer Program (NCP) prepared
a report at the request of Congress mem-
bers, who wanted to know why cancer is
still on the rise, despite spending more than
$23 billion on cancer research since 1971.
The report outlined a strategy to renew the
war and recommend direction for the
NCP. "We have a schizophrenic system,"
said Paul Calabresi, chair of the National
Cancer Advisory Board. "New direction is
urgently needed."
The subcommittee identified several
problems with current efforts to fight cancer.
One problem is that despite the progress
that has been made in cancer research, many
researchers do not have the money to con-
vert their breakthroughs in the lab into treat-
ment. Also, the subcommittee said that half
ofall cancer patients could be cured iftheir
tumors were discovered earlyenough, but 38
million uninsuredAmericans do not get rou-
tine cancer tests.
The major changes that the subcommit-
tee recommends for the program include the
establishment ofa cabinet-level cancer direc-
tor, universal access to cancer treatment, suf-
ficient financing for cancer research, and an
end to government support of tobacco,
which the National Cancer Institute says
causes one-third ofall cancer deaths.
In the report, "Cancer at a Crossroads:
A Report to Congress for the Nation," the
subcommittee recommended that three
major goals be pursued in fighting cancer:
applying current knowledge about cancer
prevention and care to all people; increas-
ing support for translational research that
develops basic cancer knowledge into pre-
ventive strategies, new technologies, and
effective treatments; and increasing support
for basic cancer research to maintain excel-
lence and accelerate progress.
To reach these goals, the subcommittee
said that six major issues must be addressed.
The report identifies each ofthe issues and
advises Congress how to address each one.
First, the subcommittee points out that
current health care reform proposals are
devastating to the war on cancer because
they deny resources for research and quality
cancer care. To address this issue, the
report says, Congress should include uni-
versal access to cancer care coverage in any
health care reform plan that includes quali-
ty preventive, diagnostic, treatment, and
rehabilitative services, including services
provided in qualified clinical trials.
Second, the report says, the NCP suffers
from an absence of coordination of cancer-
fighting efforts in the public, private, and
voluntary sectors. The 1971 National
Cancer Act that established the NCP also
mandated that the director of the National
Cancer Institute develop a coordinated can-
cer research program encompassing the NCI
programs, related programs ofother research
institutes, and other federal and nonfederal
programs. But several years later, the respon-
sibility for federal and nonfederal programs
was taken from the NCI director and given
to the general authorities of all national
research institutes. The subcommittee feels
that the scope ofthe NCP includes all non-
research, nongovernmental, and community
constituents who have an impact on cancer.
The subcommittee recommends that
Congress reestablish the 1971 legislative
authority for coordinating the NCP and
implement coordination of research and
cancer care activities throughout the public,
private, andvoluntary sectors.
The third issue that the subcommittee
points out is that many people currently
receive inadequate cancer care, especially
the poor, elderly, and uninsured. The sub-
committee advises Congress to stabilize and
strengthen the research infrastructure and
cancer care delivery system, including NCI-
designated cancer centers, community clin-
ical oncology programs, and clinical trials
cooperative groups.
Fourth, the report says that current laws,
public policy, and governmental regulation
undermine cancer prevention, treatment,
and control efforts. Among such regulations
are those regarding clinical trial design, the
approval process for additional uses ofestab-
lished cancer therapies, and excessive docu-
mentation requirements, all of which dis-
courage industry from undertaking anti-
cancer drug and technology development.
Also, the subcommittee says there is a lack
of appreciation of the potential hazards of
environmental and food source contami-
nants and that laws, policies, and regula-
tions protecting and promoting tobacco use
worsen the cancer problem and drive up
health care costs. The subcommittee advises
Congress to change such policies and indus-
try practices.
The fifth issue that the subcommittee
says warrants attention is that a failure to
support translational research, which con-
verts research findings into cancer care
products and services, hinders the develop-
ment ofcancer-fighting advances. The sub-
committee advises Congress to strengthen
essential mechanisms, funding, and other
support for translational research.
Finally, the subcommittee identifies
current investment as insufficient to capi-
talize on unprecedented opportunities in
basic science research. These opportunities
have become available as a result of an
ongoing revolution in molecular and cellu-
lar biology and offer the possibility to lead
to a better understanding ofthe process of
cancer development. In addition, the sub-
committee says that inadequate resources
now jeopardize continued basic science dis-
coveries. The subcommittee advises
Congress to intensify support for basic
research to identify the mechanisms ofcan-
cer onset and spread, which are the founda-
tion for future cancer preventive and thera-
peutic advances.
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